Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence of metabolic associated fatty liver disease (MAFLD) in patients with gallstone disease. Study on a cohort of cases in South-Southeastern Mexico
F. Roesch-Dietlen; A.G. Pérez-Morales; P. Grube-Pagola; M. González-Santes; F. Díaz-Roesch; A. Triana-Romero; L. Roesch-Ramos; J.M. Remes-Troche; M. Cruz-Aguilar;
Rev Gastroenterol Mex. 2023;88:225-31
Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024
J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;
10.1016/j.rgmxen.2024.10.009
Good clinical practice recommendations for proton pump inhibitor prescription and deprescription. A review by experts from the AMG
L.R. Valdovinos-García; A.S. Villar-Chávez; F.M Huerta-Iga; M. Amieva-Balmori; J.S. Arenas-Martínez; R. Bernal-Reyes; E. Coss-Adame; O. Gómez-Escudero; P.C. Gómez-Castaños; M. González-Martínez; E.C Morel-Cerda; J.M. Remes-Troche; M.C. Rodríguez-Leal; D. Ruiz-Romero; M.A. Valdovinos-Diaz; G. Vázquez-Elizondo; J.A. Velarde-Ruiz Velasco; M.R. Zavala-Solares;
10.1016/j.rgmxen.2024.11.002